Article Details
Retrieved on: 2023-01-10 08:35:04
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca has signed a definitive agreement to buy US-based biopharmaceutical company CinCor Pharma in a deal valued at about $1.8bn.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here